Last reviewed · How we verify
NCT05838105
Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates
NA trial testing GnRH agonist in Luteal Phase Support in 144 participants. Status unknown.
1 January 2025
Quick facts
| Lead sponsor | Shaare Zedek Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 144 |
| Start date | 1 October 2022 |
| Primary completion | 1 January 2025 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- GnRH agonist — full drug profile →
- hCG
- Progesterone 100Mg Vag Tab — full drug profile →
Conditions studied
- Luteal Phase Support — all drugs for Luteal Phase Support →
Sponsor
Shaare Zedek Medical Center
Who can join
Adults 18 to 45, female only, with Luteal Phase Support. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to compare the pregnancy rate between women treated with Gonadotropin Releasing Hormone (GnRH) agonist together with Human Chorionic Gonadotropin (HCG) and standard luteal support with progesterone following transfer of frozen embryos in in-vitro-fertilization (IVF) natural cycles.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05838105
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of GnRH agonist
Trials testing the same drug.
- NCT07269392 — Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer · Phase 4 · not yet recruiting
- NCT04356664 — Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis · Phase 2, PHASE3 · recruiting
- NCT05484193 — GnRH Agonist for Luteal Phase Support. · NA · unknown
- NCT04182594 — Cardiovascular Events in GnRH Agonist vs. Antagonist · Phase 2 · unknown
- NCT03867357 — Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia · completed
Other recruiting trials for Luteal Phase Support
Currently open trials in the same condition.
- NCT05569577 — An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients · NA · recruiting
Other Shaare Zedek Medical Center trials
Trials by the same sponsor.
- NCT05331209 — Acupuncture With/Without Self-acupressure for Post-oophorectomy Hot Flashes in BRCA Carriers · NA · not yet recruiting
- NCT06070753 — A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Str · NA · unknown
- NCT05841953 — The Use of Electrical Stimulation to Increase Anal Pressures · NA · unknown
- NCT06777706 — Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC · NA · completed
- NCT05599360 — Vyxeos for Induction of Low- or Intermediate-risk. · Phase 2 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05838105 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shaare Zedek Medical Center
- Last refreshed: 1 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05838105.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing